At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wireless Sensor Patch for Reducing Barriers to In-home Sleep Apnea Screening
In Brief
A clinical study evaluating Zansors® sleep screening device for Obstructive Sleep Apnea. Completed, enrolled 52 participants across 1 site.
Detailed Summary
Obstructive sleep apnea (OSA) is the most common type of sleep apnea. OSA affects an estimated 18-40 million adults and 0.7-3% of all children in the US. The marketplace currently does not have an affordable, easy-to-use, over-the-counter, home-based OSA screening device. An affordable, available, FDA-approved and easy-to-use over-the-counter OSA screening tool would allow greater screening of at-risk individuals, especially in underserved communities with low socioeconomic status, hopefully encouraging a greater proportion of such individuals to seek treatment for their condition. The specific goal of this project is to compare the Zansors® micro sleep sensor screening device against gold-standard polysomnography to establish the device's preliminary validity to screen for OSA accurately.
Study Details
Timeline
Interventions
Intervention is the validation of a sleep apnea screening device against the gold-standard assessment of in-laboratory polysomnography